Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

213
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
213
Drug Therapy01:28

Drug Therapy

49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
49
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

146
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biological characteristics of individuals with REM sleep behavior disorder: A multicenter prospective longitudinal cohort.

Parkinsonism & related disorders·2026
Same author

Early-Onset Parkinson's Disease: Unique Features and Management Approaches.

Current neurology and neuroscience reports·2025
Same author

Segmental and Multifocal Isolated Dystonias: Similarities and Differences.

Movement disorders clinical practice·2025
Same author

Inflammatory changes in early dementia with Lewy bodies.

Frontiers in neurology·2025
Same author

ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing.

Annals of clinical and translational neurology·2025

Related Experiment Video

Updated: Jul 13, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K

REM Behavior Disorder: Implications for PD Therapeutics.

Jeanne S Feuerstein1,2, Amy Amara3

  • 1Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. Jeanne.feuerstein@cuanschutz.edu.

Current Neurology and Neuroscience Reports
|October 13, 2023
PubMed
Summary
This summary is machine-generated.

Rapid eye movement sleep behavior disorder (RBD) is a key early sign of Parkinson's disease (PD). Research is exploring RBD treatments and its role in developing new therapies for PD.

Keywords:
MelatoninParkinson’s diseaseProdromal Parkinson’s diseaseRBDREM sleep behavior disorderSynucleinopathy

More Related Videos

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

2.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.8K

Related Experiment Videos

Last Updated: Jul 13, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

2.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.8K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Neurodegenerative Diseases

Background:

  • Rapid eye movement sleep behavior disorder (RBD) is a parasomnia characterized by REM sleep without atonia and dream enactment.
  • RBD is notably a prodromal feature of synucleinopathies, particularly Parkinson's disease (PD).

Purpose of the Study:

  • To review the current understanding of RBD, its associated diseases, and treatments.
  • To explore the implications of RBD research for developing therapeutics for Parkinson's disease.

Main Methods:

  • Review of current basic science and clinical research on RBD.
  • Investigation of animal models for RBD pathophysiology.
  • Analysis of clinical studies on RBD natural history and treatment efficacy.

Main Results:

  • RBD is increasingly recognized as a prodromal marker for PD.
  • Ongoing research focuses on RBD pathophysiology, animal models, and clinical treatments.
  • RBD offers a novel pathway for developing both neuroprotective and symptomatic PD therapies.

Conclusions:

  • RBD serves as a critical early indicator for Parkinson's disease.
  • Further basic science and clinical research into RBD is essential for advancing PD therapeutics.
  • Investigating RBD provides a unique opportunity to develop innovative treatments for PD.